Patent application number | Description | Published |
20130039340 | METHOD, APPARATUS AND SYSTEM FOR REDIRECTING DATA TRAFFIC - A method, apparatus and system for resource allocation in redirection of data traffic are provided. The method includes receiving a message including a subscription identification, position information associated with the subscription and an action proposal associated with the subscription ( | 02-14-2013 |
20130042316 | METHOD AND APPARATUS FOR REDIRECTING DATA TRAFFIC - A method and apparatus for redirecting data traffic are provided. The method includes receiving a service request from a first device, allocating resources for the service, associating the resources with a first unique identifier, confirming the service request with the first device, receiving a connection request from a second device including the first unique identifier and an authentication certificate, passing the authentication certificate to the first device, and receiving an authentication confirmation from the first device. The method further includes, in response to receiving the authentication confirmation, accepting the connection request from the second device, providing an indication regarding at least one lo-cal area network to the second device, and providing required credentials associated with the at least one local area network to the second device. | 02-14-2013 |
20130044741 | Redirecting of data traffic between wan and lan - A method and apparatus for redirecting data traffic, the method includes exchanging user data over a wireless connection with a destination identified by an Internet Protocol address using a wide area bearer, receiving, over the wide area bearer, an off-loading indication message including address information of at least one local access server, exchanging signalling messages including information regarding one or more available local access networks with the at least one local access server specified in the off-loading indication message, selecting a local access network based at least part on information exchanged with the at least one local access server and on information regarding wireless signal coverage activating a supplementary wireless local area bearer based at least part on information regarding one or more available local access networks received from the at least one local access server, and routing new connection opening requests to the supplementary wireless local area bearer. | 02-21-2013 |
Patent application number | Description | Published |
20110033872 | METHOD AND APPARATUS FOR DETECTING UNDESIRED MEASUREMENT CONDITIONS - The invention relates to a method and apparatus for detecting undesired measurement conditions in a sample container. The method comprises measuring a fluorescent property of the sample container comprising a sample substrate with impregnated blood sample and incubation buffer to which the blood sample is to be eluted, and determining, based on temporal and/or spectral characteristics of the fluorescent property, whether the fluorescent property is characteristic to a sample container comprising a sample substrate and incubation buffer under said undesired measurement conditions or to a sample container suitable for optical measurement of analyte contained in the sample. Thus undesired measurement condition can be a floating sample substrate or a foreign body in the sample container. By means of the invention, reliability of neonatal screening, for example, can be increased. | 02-10-2011 |
20110117571 | Transporter assay - This invention concerns a non-radioactive homogenous proximity assay for cellular transport system. The assay format disclosed here takes advantageous of the fact that ABC transporters have two similar ATP binding sites, and thus allowing two ATP molecules to bind simultaneously to these adjacent sites. | 05-19-2011 |
20110294227 | METHOD FOR DETERMINING THE RISK OF PREECLAMPSIA USING PIGF-2 AND PIGF-3 MARKERS - The present invention relates to a method for determining the risk of a pregnant woman developing pre-eclampsia. The method comprises i) determining the level of one or more biochemical markers in a sample obtained from a pregnant woman, and ii) comparing the level of the at least one biochemical marker in the sample with the level of the same biochemical marker in a control sample. A difference in the level of the biochemical marker in the sample relative to the control sample is indicative of an increased risk of developing pre-eclampsia. The isoform biochemical markers are preferably P1GF-2 and P1GF-3. The present invention relates also to a method for determining whether a pregnant woman has pre-eclampsia and as well as a kit for assessing the risk or presence of pre-eclampsia. In addition, the invention relates also to a computer program used in these determinations. | 12-01-2011 |
20120045784 | BIOTINIDASE ASSAY - The present technology discloses biotinidase assay, biotinidase substrates (I) and a kit wherein the biotinidase substrate includes a label molecule separated from the biotin carbamoyl group by a linker X longer than about 4 Å but shorter than about 27 Å. | 02-23-2012 |
20140273024 | SYSTEM AND METHOD FOR DETERMINING RISK OF DIABETES BASED ON BIOCHEMICAL MARKER ANALYSIS - A method for predicting risk of gestational diabetes mellitus (GDM) in a pregnant individual includes measuring one or more biochemical markers in a blood sample obtained from the pregnant individual to determine one or more biomarker levels, where the one or more measured biochemical markers includes at least one of PAI-2 and sTNFR1, identifying, for each of the one or more measured biochemical markers, a difference between the measured biomarker level and a corresponding predetermined control level, and, responsive to the identifying, determining a prediction corresponding to a relative risk of the pregnant individual having or developing GDM. | 09-18-2014 |
20140273025 | SYSTEM AND METHOD FOR DETERMINING RISK OF PRE-ECLAMPSIA BASED ON BIOCHEMICAL MARKER ANALYSIS - A method for predicting risk of pre-eclampsia in a pregnant individual includes measuring one or more biochemical markers including an RBP4 biochemical marker in a blood sample obtained from the pregnant individual to determine one or more biomarker levels including an RBP4 biomarker level, identifying, for each of the one or more measured biochemical markers, a difference between the measured biomarker level and a corresponding predetermined control level, and, responsive to the identifying, determining a prediction corresponding to a relative risk of the pregnant individual having or developing pre-eclampsia. | 09-18-2014 |